Vericel Corp.
(NASDAQ : ASTM)

( )
ASTM PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.01%470.031.0%$957.85m
ABTAbbott Laboratories 0.01%110.490.8%$870.97m
DHRDanaher Corp. -0.93%245.100.7%$636.27m
MDTMedtronic Plc 0.81%125.160.6%$601.95m
ISRGIntuitive Surgical, Inc. -0.05%872.362.3%$473.07m
BDXBecton, Dickinson & Co. -0.59%241.301.0%$346.18m
DXCMDexCom, Inc. -0.98%405.107.8%$295.39m
ALGNAlign Technology, Inc. -0.94%600.056.3%$278.28m
SYKStryker Corp. 0.47%256.881.3%$270.10m
BSXBoston Scientific Corp. 0.45%42.731.0%$264.59m
EWEdwards Lifesciences Corp. -0.62%100.330.4%$234.35m
BAXBaxter International, Inc. -1.04%81.911.8%$223.03m
AAgilent Technologies, Inc. 0.10%144.541.6%$202.33m
STESTERIS Plc (Ireland) -0.17%198.043.1%$191.58m
ZBHZimmer Biomet Holdings, Inc. 0.43%158.231.7%$187.39m

Company Profile

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.